Earlier this year, Peter Rotwein, M.D., was appointed to the Cancer Prevention and Research Institute of Texas (CPRIT)’s University Advisory Committee (UAC).
“Dr. Peter Rotwein’s appointment to the CPRIT’s UAC is a testament to his professional success and commitment to others,” said Texas Tech University System (TTU System) Chancellor Robert Duncan. “He will be a tremendous resource for CPRIT and the state of Texas.”
As the TTU System representative, Dr. Rotwein will help advise the organization’s Oversight Committee on the role of higher education in cancer research.
“CPRIT plays a critical role in improving the health of Texans by investing in the highest quality fundamental and clinical cancer research,” said Dr. Rotwein, who is also Texas Tech University Health Sciences Center El Paso (TTUHSC El Paso)’s vice president for research. “This role comes with the twin goals of more effective treatments now and enhanced progress toward cures in the future.”
In addition to helping advise the institute’s Oversight Committee — a committee of nine Texans appointed by the Texas governor, lieutenant governor, and speaker of the House — Dr. Rotwein will advise CPRIT on how Texas universities and other institutions of higher education can assist in furthering the organization’s dual goals.
“I look forward to participating in this important task, and in representing our university, the citizens of West Texas, and the entire state in helping our scientists and clinicians make cancer disappear,” said Dr. Rotwein.
Dr. Rotwein joined TTUHSC El Paso in 2014.